Data / Research funding / Adult/Somatic Stem Cell and Progenitor Cell Research
Adult/Somatic Stem Cell and Progenitor Cell Research: 2,265 NIH awards ($3.1B) to 299 organizations
2,265 NIH awards ($3.1B) in the NIH spending category Adult/Somatic Stem Cell and Progenitor Cell Research, to 299 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
Get awards on Adult/Somatic Stem Cell and Progenitor Cell ResearchWatch Adult/Somatic Stem Cell and Progenitor Cell Research
- Topic
- NIH spending category
Awards
The 500 largest of 2,265 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | NIH | National Cancer Institute | 2021 to 2025 | $30,268,190 | March 1, 1998 | February 29, 2028 | SHAW, BRONWEN | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $8,479,606 | May 1, 2021 | April 30, 2027 | EFRON, PHILIP A | reporter.nih.gov |
| Early Phase Clinical Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,613,555 | July 7, 2020 | July 31, 2031 | SCHUETZE, SCOTT MICHAEL | reporter.nih.gov |
| Application of Progenitor Niche Signals to Ex Vivo Nephrogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,389,413 | September 15, 2021 | June 30, 2027 | OXBURGH, LEIF | reporter.nih.gov |
| TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,251,380 | September 1, 2021 | May 31, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,084,951 | May 15, 2023 | March 31, 2028 | NDHLOVU, LISHOMWA C | reporter.nih.gov |
| The impact of genomic variation on environment-induced changes in pancreatic beta cell states | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,795 | September 7, 2021 | May 31, 2027 | CARTER, HANNAH KATHRYN | reporter.nih.gov |
| Multimodal histologic atlas of human bone marrow | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,888,084 | August 1, 2022 | June 30, 2026 | BENDALL, SEAN CURTIS | reporter.nih.gov |
| Environmental Biosensors in the Oligodendrocyte Lineage | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,732,603 | May 15, 2019 | April 30, 2027 | CASACCIA, PATRIZIA | reporter.nih.gov |
| The role of stem cells and the microenvironment in gastrointestinal cancers | NIH | National Cancer Institute | 2021 to 2025 | $5,569,272 | January 7, 2016 | August 31, 2030 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Cell plasticity in the origin of gastric carcinogenesis | NIH | National Cancer Institute | 2022 to 2025 | $5,262,457 | September 1, 2025 | August 31, 2027 | CHOI, EUNYOUNG | reporter.nih.gov |
| Continuous Neurogenesis in the Mammalian Hippocampus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,244,633 | May 1, 2020 | April 30, 2028 | SONG, HONGJUN | reporter.nih.gov |
| Novel therapeutic development for small cell lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,214,420 | August 10, 2021 | July 31, 2028 | RUDIN, CHARLES M. | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Novel Strategies to Improve Blood Transfusion Practice | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,119,758 | August 15, 2022 | July 31, 2027 | LUO, HONGBO R | reporter.nih.gov |
| UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (UCLA HT-NPC) | NIH | National Institute of Mental Health | 2023 to 2025 | $5,035,081 | May 1, 2023 | April 30, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,032,505 | September 21, 2024 | July 31, 2029 | JENQ, ROBERT | reporter.nih.gov |
| 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,023,972 | April 1, 2022 | March 31, 2029 | SHAW, BRONWEN | reporter.nih.gov |
| Novel vascular smooth muscle cell progenitors in development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,999,830 | July 1, 2020 | June 30, 2027 | GREIF, DANIEL | reporter.nih.gov |
| Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,948,268 | September 1, 2025 | August 31, 2027 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,937,681 | May 6, 2022 | April 30, 2027 | SCOTT, JESSICA | reporter.nih.gov |
| Experimental Cellular Approaches to Genotype × Environment Interaction | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $4,934,544 | September 7, 2023 | August 31, 2028 | CURRAN, JOANNE E. | reporter.nih.gov |
| Investigating the heterogeneity and coordination of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,840,269 | August 1, 2020 | July 31, 2027 | LU, RONG | reporter.nih.gov |
| Program to promote lung regeneration and block fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,819,926 | February 15, 2020 | February 14, 2026 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Durable HIV Vaccine Targeting Mucosal Epithelium | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,751,308 | August 1, 2022 | July 31, 2027 | GAUDUIN, MARIE-CLAIRE ELISABETH | reporter.nih.gov |
| Defining mechanisms driving salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,717,861 | September 18, 2018 | June 30, 2026 | KNOX, SARAH MONICA | reporter.nih.gov |
| Defining and Controlling Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,706,100 | March 8, 2019 | February 28, 2026 | HOLTZMAN, MICHAEL J | reporter.nih.gov |
| Development of Innovative Resources to Advance MDS Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,661,966 | September 15, 2023 | July 31, 2028 | BLEAKLEY, MARIE | reporter.nih.gov |
| Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,613,595 | June 3, 2022 | May 31, 2027 | KAWAI, TATSUO | reporter.nih.gov |
| Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation | NIH | National Cancer Institute | 2021 to 2025 | $4,608,771 | April 1, 2017 | July 31, 2031 | COFFEY, ROBERT J. | reporter.nih.gov |
| Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting | NIH | National Cancer Institute | 2021 to 2025 | $4,594,192 | September 1, 2021 | August 31, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Cell signaling in development and regeneration | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,582,546 | May 6, 2016 | July 9, 2026 | JIANG, JIN | reporter.nih.gov |
| Therapeutic Targeting of Human AML Stem Cells | NIH | National Cancer Institute | 2021 to 2025 | $4,546,001 | September 8, 2020 | August 31, 2027 | JORDAN, CRAIG T. | reporter.nih.gov |
| Pathological Mechanisms of Human Cerebellar Malformations | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,519,501 | September 1, 2016 | June 30, 2028 | MILLEN, KATHLEEN JOYCE | reporter.nih.gov |
| Mechanisms of Developmental Myelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,505,832 | May 15, 2021 | April 30, 2029 | APPEL, BRUCE H | reporter.nih.gov |
| A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,411,202 | December 21, 2016 | June 30, 2026 | SACHA, JONAH B. | reporter.nih.gov |
| Cell-cell interactions governing lung epithelial progenitor cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,407,300 | March 15, 2020 | January 31, 2027 | KIM, CARLA F. | reporter.nih.gov |
| Regulation of proliferation and differentiation in the male germ line adult stem cell lineage | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,349,146 | June 1, 2020 | May 31, 2030 | FULLER, MARGARET T | reporter.nih.gov |
| Impact of Infection and Inflammation on Primitive Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,290,831 | July 1, 2021 | June 30, 2028 | KING, KATHERINE YUDEH | reporter.nih.gov |
| Charting human islet maturation via combined soft nanoelectronics and single-cell spatial transcriptomics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,276,659 | September 17, 2021 | May 31, 2027 | LIU, JIA | reporter.nih.gov |
| Data science approaches to autism: environmental modulators of the transcriptome and gene-x-environment interactions | NIH | Office of the Director, National Institutes of Health | 2025 | $4,255,873 | September 29, 2025 | September 28, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Molecular Regulation of Progressive Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,220,741 | March 1, 2020 | February 28, 2027 | NOBLE, PAUL WESLEY | reporter.nih.gov |
| MSC Exosome Treatment for BPD: Impact on Immunity and Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,182,213 | March 1, 2019 | February 28, 2027 | KOUREMBANAS, STELLA | reporter.nih.gov |
| Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,065,243 | March 15, 2021 | February 28, 2027 | DEBAUN, MICHAEL R. | reporter.nih.gov |
| Base editing and prime editing for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,000,055 | January 1, 2021 | June 30, 2030 | WEISS, MITCHELL J | reporter.nih.gov |
| Impact of chronic alcohol consumption on the functional and epigenetic landscapes of monocytes and their progenitors | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,998,523 | September 1, 2020 | August 31, 2029 | MESSAOUDI, ILHEM | reporter.nih.gov |
| Combining Targeted RIT and Synergistic Novel Agent-Renewal | NIH | National Cancer Institute | 2021 to 2025 | $3,984,924 | June 1, 2020 | May 31, 2027 | OROZCO, JOHNNIE JOSE | reporter.nih.gov |
| Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,964,079 | January 1, 2022 | December 31, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| Coronal Suture Development in Health and Disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,959,879 | September 20, 2021 | July 31, 2027 | HOLMES, GREG PETER | reporter.nih.gov |
| Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,911,609 | August 1, 2015 | July 31, 2028 | KAPUR, REUBEN | reporter.nih.gov |
| Generation of a temporal, spatial, and molecular map of in situ hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,870,336 | September 15, 2022 | May 31, 2027 | CAMARGO, FERNANDO | reporter.nih.gov |
| T cells in the aging brain | NIH | National Institute on Aging | 2021 to 2025 | $3,850,998 | June 15, 2021 | March 31, 2027 | BRUNET, ANNE | reporter.nih.gov |
| Understanding Skin Tissue Repair in Live Mammals | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,829,886 | March 1, 2018 | August 31, 2027 | GRECO, VALENTINA | reporter.nih.gov |
| The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,815,411 | February 1, 2010 | April 30, 2028 | MISRA, SANJAY | reporter.nih.gov |
| Cell competition in pulmonary fibrosis and ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,796,920 | August 20, 2022 | July 31, 2029 | DE LANGHE, STIJN PIET JOHAN | reporter.nih.gov |
| Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,747,870 | August 1, 2021 | May 31, 2027 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Ikaros regulation: study on hemo-lymphopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,733,682 | September 5, 2011 | March 31, 2029 | GEORGOPOULOS, KATIA | reporter.nih.gov |
| Live Imaging of Skin Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,713,235 | September 7, 2012 | August 31, 2027 | GRECO, VALENTINA | reporter.nih.gov |
| "Corral and Kill" strategy for HIV eradication using MSC in an SIV model | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,712,736 | March 23, 2020 | February 28, 2030 | DANDEKAR, SATYA | reporter.nih.gov |
| Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,710,340 | September 1, 2023 | August 31, 2028 | WEISS, MITCHELL J | reporter.nih.gov |
| Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $3,687,540 | September 7, 2017 | June 30, 2032 | DIPERSIO, JOHN F. | reporter.nih.gov |
| Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. | NIH | National Cancer Institute | 2021 to 2025 | $3,654,173 | April 5, 2021 | March 31, 2027 | CHAN, ANDREW T | reporter.nih.gov |
| Emulating Immune Dysregulation by Trisomy 21 in a Multi-Organ-on-a-Chip System | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,649,414 | September 20, 2021 | July 31, 2026 | HAJIPOURAN BENAM, KAMBEZ | reporter.nih.gov |
| Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,648,726 | August 15, 2015 | May 31, 2026 | SARANTOPOULOS, STEFANIE | reporter.nih.gov |
| Defining gene regulatory networks driving cortical evolution and brain development | NIH | National Institute of Mental Health | 2021 to 2025 | $3,647,249 | July 1, 2021 | April 30, 2027 | DE LA TORRE-UBIETA, LUIS | reporter.nih.gov |
| Systems genetics analysis of tumor evolution in the mouse | NIH | National Cancer Institute | 2021 to 2025 | $3,631,667 | June 1, 2017 | July 31, 2032 | BALMAIN, ALLAN | reporter.nih.gov |
| Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,620,000 | August 1, 2022 | July 31, 2027 | SHETTY, ASHOK K | reporter.nih.gov |
| HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,601,018 | April 9, 2021 | March 31, 2027 | HSU, KATHARINE C | reporter.nih.gov |
| New technologies to identify molecular regulators of the human hippocampus neurogenic niche in healthy aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,598,243 | May 15, 2022 | February 28, 2027 | DUPONT, MAURA BOLDRINI | reporter.nih.gov |
| Probing cytosolic nucleic acid sensing pathways in cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,548,978 | January 1, 2021 | December 31, 2026 | LAUGHNEY, ASHLEY MARIE | reporter.nih.gov |
| Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,548,396 | January 18, 2019 | June 30, 2027 | WEISER-EVANS, MARY CM | reporter.nih.gov |
| Preventing GVHD by inhibition of alloantigen presentation in the gut | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,543,040 | July 1, 2019 | June 30, 2027 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Ocular Immune Regulation by Mesenchymal Stem Cells | NIH | National Eye Institute | 2021 to 2025 | $3,542,949 | April 1, 2015 | September 14, 2028 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $3,540,268 | July 1, 2022 | March 31, 2027 | ENIKOLOPOV, GRIGORI N | reporter.nih.gov |
| Impact of the Human Herpesvirus 6A (HHV6A) latency gene U94A on Alzheimer disease pathology | NIH | National Institute on Aging | 2021 to 2025 | $3,507,363 | September 30, 2021 | May 31, 2026 | MAYER-PROSCHEL, MARGOT | reporter.nih.gov |
| Craniofacial Morphogenesis in Prenatal Alcohol Exposure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,497,846 | July 1, 1996 | August 31, 2029 | SMITH, SUSAN M. | reporter.nih.gov |
| A Long Noncoding RNA Amerliorates Periodontitis via Distinct Epigenetic Pathways | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,494,925 | December 1, 2020 | November 30, 2026 | CHEN, JAKE JINKUN | reporter.nih.gov |
| Identifying Relapse Predictors and Therapeutic Vulnerabilities in Ph+ and Ph-like Acute Lymphoblastic Leukemia | NIH | National Cancer Institute | 2025 | $3,480,276 | August 1, 2025 | July 31, 2029 | LOH, MIGNON LEE-CHEUN | reporter.nih.gov |
| Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,479,164 | February 17, 2016 | April 30, 2027 | SURESH, MARULASIDDAPPA | reporter.nih.gov |
| Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation | NIH | National Cancer Institute | 2021 to 2025 | $3,469,202 | September 1, 2021 | August 31, 2027 | MOSTOUFI-MOAB, SOGOL | reporter.nih.gov |
| Defining mechanisms of disease and repair in a viral model of multiple sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,467,101 | May 1, 2020 | April 30, 2029 | LANE, THOMAS E | reporter.nih.gov |
| Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,457,708 | July 1, 2021 | April 30, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,434,150 | December 16, 1994 | June 30, 2030 | WALSH, CHRISTOPHER A. | reporter.nih.gov |
| Preserving physical function in patients with kidney disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,428,324 | August 3, 2021 | June 30, 2026 | ABRAMOWITZ, MATTHEW K | reporter.nih.gov |
| Chemical tools for developmental biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,426,216 | April 1, 2018 | June 30, 2028 | CHEN, JAMES K | reporter.nih.gov |
| The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,406,145 | August 8, 2025 | July 31, 2029 | FUJISAKI, JOJI | reporter.nih.gov |
| Remediating fibrosis for salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,392,837 | April 1, 2019 | March 31, 2029 | LARSEN, MELINDA | reporter.nih.gov |
| Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,369,470 | July 7, 2016 | December 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Regulation of Hemoglobin Switching | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,354,270 | August 5, 2013 | January 31, 2027 | BLOBEL, GERD A | reporter.nih.gov |
| Cellular and molecular mechanisms underlying DDX3X syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,350,844 | January 1, 2021 | November 30, 2026 | SILVER, DEBRA L. | reporter.nih.gov |
| Dystrophin Replacement | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,349,499 | April 1, 1991 | April 30, 2026 | CHAMBERLAIN, JEFFREY S | reporter.nih.gov |
| Regulation of Progenitor Cell Plasticity in Lung Development and Disease-Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,331,553 | July 1, 2023 | June 30, 2030 | CARDOSO, WELLINGTON V. | reporter.nih.gov |
| The Primate Corticospinal Connectome and Transcriptome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,321,910 | September 15, 2017 | May 31, 2026 | TUSZYNSKI, MARK H. | reporter.nih.gov |
| Novel Mechanisms of Exercise Training Effects on Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,320,917 | April 10, 2014 | December 31, 2028 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Immunobiology of the normal and injured lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,312,758 | January 1, 2022 | December 31, 2028 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| Proteogenetics of Autism Spectrum Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $3,288,305 | August 1, 2013 | June 30, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Extracellular Vesicle treatment and age-related neuropathology in non-human primates | NIH | National Institute on Aging | 2025 | $3,284,677 | September 15, 2020 | August 31, 2029 | MOORE, TARA L | reporter.nih.gov |
| Decoding innate immune signaling in normal and myelodysplastic hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,283,833 | January 1, 2023 | December 31, 2029 | STARCZYNOWSKI, DANIEL | reporter.nih.gov |
| The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia | NIH | National Cancer Institute | 2022 to 2025 | $3,273,998 | September 1, 2022 | August 31, 2027 | ABRAMS, JULIAN | reporter.nih.gov |
| Development of novel genomic approaches for profiling cellular temporal-spatial dynamics of neurogenesis in Aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $3,270,531 | June 1, 2022 | February 28, 2027 | CAO, JUNYUE | reporter.nih.gov |
| Histone lactylation pathway in hair cycle: deacylases and their protein targets | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,263,621 | July 1, 2021 | April 30, 2026 | ZHAO, YINGMING | reporter.nih.gov |
| Mechanisms of Beta Cell Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,260,500 | July 1, 2003 | July 31, 2026 | ACCILI, DOMENICO | reporter.nih.gov |
| Identification of enteric Juvenile Protective Factors and their role in stimulating neurogenesis in the adult and ageing Enteric Nervous System | NIH | National Institute on Aging | 2021 to 2025 | $3,254,354 | January 15, 2021 | December 31, 2026 | GOFF, LOYAL ANDREW | reporter.nih.gov |
| Genetic Studies of Cortex Structure and Development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,251,011 | September 30, 2016 | June 30, 2026 | RUBENSTEIN, JOHN L. R. | reporter.nih.gov |
| A spatial view of hematopoietic regeneration dynamics in the bone marrow | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,245,428 | September 15, 2024 | July 31, 2029 | LU, RONG | reporter.nih.gov |
| Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population Control | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,243,464 | September 1, 2021 | August 31, 2026 | WEISS, RON | reporter.nih.gov |
| Targeting innate immunity for induction of robust renal allograft tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,224,166 | July 25, 2023 | April 30, 2028 | KAWAI, TATSUO | reporter.nih.gov |
| Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,224,130 | January 19, 2022 | December 31, 2026 | RUTISHAUSER, RACHEL LENA | reporter.nih.gov |
| Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,223,525 | December 7, 2020 | November 30, 2026 | KUKURUZINSKA, MARIA A. | reporter.nih.gov |
| Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,219,338 | February 15, 2020 | July 31, 2029 | TUGGLE, CHRISTOPHER | reporter.nih.gov |
| Regulation of Epidermal Development and Differentiation-Renewal | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,420 | January 1, 1983 | May 31, 2026 | FUCHS, ELAINE | reporter.nih.gov |
| Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,262 | September 20, 2013 | June 30, 2028 | PYLE, APRIL D | reporter.nih.gov |
| Novel Molecular Biomarkers of Bone Microarchitecture | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,202,138 | September 30, 1991 | March 31, 2027 | KIEL, DOUGLAS P. | reporter.nih.gov |
| Progenitors, Mechanisms of Differentiation, and Functions of Lung M Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,180,672 | August 1, 2022 | July 31, 2026 | RAJAGOPAL, JAYARAJ | reporter.nih.gov |
| Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,169,762 | August 24, 2021 | May 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Hematopoietic Stem Cell And Cord Blood Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,169,146 | September 30, 2005 | May 31, 2030 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Cellular Reinnervation Therapy for Vocal Fold Paralysis | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,161,418 | August 4, 2021 | May 31, 2027 | HALUM, STACEY L. | reporter.nih.gov |
| Immunomodulation by splenic megakaryocytes and platelets in sepsis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,151,437 | June 7, 2022 | May 31, 2027 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| Engineering Vascularized Cardiac Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,149,452 | July 1, 2005 | March 31, 2027 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| Harnessing Novel Human Endocrine Progenitor Biology for Enhanced Generation of Beta Cells from Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,140,632 | September 1, 2025 | August 31, 2029 | SNEDDON, JULIE BETH | reporter.nih.gov |
| Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,134,067 | June 1, 2019 | March 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| A DUAL CHIMERIC HUMAN ASTROGLIAL-MICROGLIAL MODEL OF HIV AND HAND | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,125,946 | August 1, 2021 | May 31, 2026 | GOLDMAN, STEVEN ALAN | reporter.nih.gov |
| PFAS exposure is detrimental to placental function and fetal development by disrupting mitochondrial function and metabolism | NIH | National Institute of Environmental Health Sciences | 2025 | $3,121,590 | September 5, 2025 | September 4, 2029 | FENG, LIPING | reporter.nih.gov |
| Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,121,383 | August 15, 2022 | July 31, 2026 | YANIK, GREGORY A | reporter.nih.gov |
| Defective heme transport in the development of congenital hydrocephalus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,120,419 | September 1, 2021 | June 30, 2026 | ARNOLD, THOMAS DARMODY | reporter.nih.gov |
| Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation | NIH | National Cancer Institute | 2021 to 2025 | $3,120,296 | August 1, 2021 | July 31, 2027 | HAHN, THERESA E | reporter.nih.gov |
| Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation. | NIH | National Cancer Institute | 2021 to 2025 | $3,119,515 | July 1, 2020 | June 30, 2027 | VINCENT, BENJAMIN G | reporter.nih.gov |
| Penetrating the “Black box”: Prediction of early Bronchiolitis obliterans in Pediatric Hematopoietic Stem Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,117,523 | July 15, 2021 | April 30, 2027 | MYERS, KASIANI | reporter.nih.gov |
| Neural stem cell rejuvenation through single cell pharmacogenomics | NIH | National Institute on Aging | 2022 to 2025 | $3,117,021 | June 15, 2022 | February 28, 2027 | BONAGUIDI, MICHAEL | reporter.nih.gov |
| Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,102,648 | August 4, 2021 | May 31, 2027 | ADAMS, PETER D. | reporter.nih.gov |
| A beneficial persistent DNA damage-induced immune response in aging | NIH | National Institute on Aging | 2025 | $3,101,237 | September 1, 2025 | August 31, 2029 | DU, WEI | reporter.nih.gov |
| Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,096,729 | September 12, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Lineage Progression of Cortical Neural Stem Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,090,762 | May 15, 2015 | July 31, 2027 | CHEN, BIN | reporter.nih.gov |
| Pathogenic monocyte response to chronic lung inflammation in cystic fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,086,283 | January 1, 2022 | November 30, 2026 | BRUSCIA, EMANUELA MARINA | reporter.nih.gov |
| Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,081,005 | December 1, 2021 | November 30, 2025 | FUJISAKI, JOJI | reporter.nih.gov |
| Anti-inflammatory Cell Based Repair of Intervertebral Disc Degeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,075,117 | September 1, 2021 | August 31, 2026 | CHAHINE, NADEEN O. | reporter.nih.gov |
| BIOLOGICAL EMBEDDING OF CONTEXTUAL FACTORS IN HUMAN STEM CELLS: IMPLICATIONS FOR POPULATION HEALTH DIFFERENCES | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,074,250 | September 26, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| A transdisciplinary approach for dissecting stem cell states in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,070,312 | September 20, 2021 | August 31, 2026 | RABADAN, RAUL | reporter.nih.gov |
| Role of the Cell Death Machinery in a Somatic Autoinflammatory Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,066,524 | August 21, 2025 | July 31, 2029 | GITLIN, ALEXANDER | reporter.nih.gov |
| Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance | NIH | National Cancer Institute | 2021 to 2025 | $3,062,772 | September 22, 2021 | August 31, 2026 | MUNN, LANCE L. | reporter.nih.gov |
| First Aid Medicine to Treat Vesicant Induced Corneal Injury | NIH | National Eye Institute | 2022 to 2025 | $3,055,554 | September 30, 2022 | August 31, 2027 | CHANDLER, HEATHER | reporter.nih.gov |
| Molecular and Cellular Basis of Craniosynostosis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,051,443 | July 1, 2016 | July 31, 2026 | CRUMP, GAGE D | reporter.nih.gov |
| Microengineering vascularized and innervated bone-like scaffolds as an alternative to autologous bone grafts | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,048,776 | August 1, 2021 | April 30, 2027 | BERTASSONI, LUIZ EDUARDO | reporter.nih.gov |
| Using MR Spectroscopy to Measure Mammalian Neurogenesis in Vivo | NIH | National Institute on Aging | 2022 to 2025 | $3,042,523 | June 1, 2022 | February 28, 2027 | MALETIC-SAVATIC, MIRJANA | reporter.nih.gov |
| Hippocampal neurogenesis in cognitive function and dysfunction in Alzheimer's disease. | NIH | National Institute on Aging | 2022 to 2025 | $3,035,322 | May 15, 2022 | April 30, 2027 | LAZAROV, ORLY | reporter.nih.gov |
| Molecular Drivers of Human Gliogenesis | NIH | National Institute of Mental Health | 2021 to 2025 | $3,033,949 | August 1, 2021 | May 31, 2026 | SLOAN, STEVEN A | reporter.nih.gov |
| Early cardiac progenitors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,025,531 | July 1, 2013 | July 31, 2029 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,020,733 | September 15, 2022 | July 31, 2027 | YANG, PEIXIN | reporter.nih.gov |
| Mechanisms and rescue of craniosynostosis associated with gene-environment interaction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,011,888 | July 1, 2021 | April 30, 2027 | CHEN, JIANFU | reporter.nih.gov |
| Mechanisms of T Cell Quiescence and Exhaustion | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,001,713 | March 1, 2019 | February 28, 2029 | SARKAR, SUROJIT | reporter.nih.gov |
| (PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,993,160 | April 8, 2021 | March 31, 2027 | SHEMBADE, NOULA DATTU | reporter.nih.gov |
| Targeting MicroRNAs to Eradicate Leukemia Stem Cells | NIH | National Cancer Institute | 2021 to 2025 | $2,990,517 | August 1, 2017 | July 31, 2027 | KUO, YA-HUEI | reporter.nih.gov |
| Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell | NIH | National Cancer Institute | 2022 to 2025 | $2,988,832 | September 12, 2022 | August 31, 2027 | LIU, SHUJUN | reporter.nih.gov |
| Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1 | NIH | National Cancer Institute | 2021 to 2025 | $2,988,590 | March 1, 2021 | February 28, 2026 | PARK, CHRISTOPHER Y | reporter.nih.gov |
| Adhesion G Protein-Coupled Receptors in CNS Development and Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,987,194 | September 30, 2015 | May 31, 2027 | PIAO, XIANHUA | reporter.nih.gov |
| Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid Neoplasms | NIH | National Cancer Institute | 2021 to 2025 | $2,986,870 | July 1, 2021 | June 30, 2026 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Stem Cell and Transplantation Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,984,057 | August 1, 2015 | July 31, 2028 | STIREWALT, DEREK L | reporter.nih.gov |
| Blood vessel assembly from multipotent hemangioma-derived stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,982,138 | April 1, 2009 | April 30, 2028 | BISCHOFF, JOYCE E. | reporter.nih.gov |
| Integration and functionality of retinal organoid transplants | NIH | National Eye Institute | 2021 to 2025 | $2,971,351 | May 1, 2021 | March 31, 2027 | SEILER, MAGDALENE J | reporter.nih.gov |
| Developmental programming of adult stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,970,076 | September 15, 2025 | September 14, 2029 | MANA, MIYEKO | reporter.nih.gov |
| Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,969,354 | September 1, 2025 | August 31, 2027 | CHEN, YU | reporter.nih.gov |
| Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,966,978 | December 1, 2021 | November 30, 2026 | CHENG, GUANG-SHING | reporter.nih.gov |
| Systems biology of intratumoral heterogeneity in glioblastoma | NIH | National Cancer Institute | 2022 to 2025 | $2,962,426 | January 1, 2022 | December 31, 2026 | BALIGA, NITIN S | reporter.nih.gov |
| Cell Fate Decisions in Epithelial Stem Cell Lineages | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,957,506 | July 1, 2020 | May 31, 2030 | NYSTUL, TODD | reporter.nih.gov |
| Therapeutic Targets for Niemann-Pick Type C Neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,954,773 | August 15, 2021 | July 31, 2026 | LIEBERMAN, ANDREW P | reporter.nih.gov |
| Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,948,443 | August 6, 2021 | December 31, 2026 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cells | NIH | National Institute on Aging | 2021 to 2025 | $2,943,876 | September 15, 2019 | May 31, 2029 | FORSBERG, CAMILLA | reporter.nih.gov |
| Clonal hematopoiesis, inflammasomes and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,941,081 | February 15, 2021 | January 31, 2029 | TALL, ALAN RICHARD | reporter.nih.gov |
| Regulation of hematopoiesis by ribosomal protein paralogs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,934,669 | February 1, 2025 | January 31, 2030 | WIEST, DAVID L. | reporter.nih.gov |
| Backtracking Leukemia-Typical Somatic Alterations in Cord Blood at Single-cell Resolution | NIH | National Cancer Institute | 2021 to 2025 | $2,927,357 | August 1, 2021 | July 31, 2026 | SPECTOR, LOGAN G. | reporter.nih.gov |
| Specification, Molecular Control and Niche Functions of the Hair Follicle Mesenchyme | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,922,092 | September 15, 2016 | August 31, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Tissue Engineered Rostral Migratory Stream for Directed Neuronal Replacement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,919,684 | April 1, 2021 | March 31, 2026 | CULLEN, DANIEL KACY | reporter.nih.gov |
| Mechanisms of epitranscriptomic regulation in cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,917,446 | September 10, 2014 | August 31, 2029 | JAFFREY, SAMIE R | reporter.nih.gov |
| Modeling myelodysplasia | NIH | National Cancer Institute | 2021 to 2025 | $2,916,597 | January 1, 2021 | December 31, 2026 | GRIMES, H. LEIGHTON | reporter.nih.gov |
| Identification of metabolic alterations during cortical development in a human cellular model for 22q11.2 deletion syndrome | NIH | National Institute of Mental Health | 2022 to 2025 | $2,912,854 | January 18, 2022 | October 31, 2026 | PASCA, ANCA MIRABELA | reporter.nih.gov |
| iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,907,792 | August 1, 2022 | May 31, 2027 | REHMAN, JALEES | reporter.nih.gov |
| Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation | NIH | National Institute on Aging | 2021 to 2025 | $2,907,195 | September 15, 2021 | June 30, 2027 | TROWBRIDGE, JENNIFER JEAN | reporter.nih.gov |
| The DNA damage response of fast-cycling erythroblasts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,899,464 | August 25, 2021 | October 31, 2026 | SOCOLOVSKY, MERAV | reporter.nih.gov |
| Dissecting Yersinia Yop Targets in Neutrophils | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,883,504 | February 11, 2022 | January 31, 2027 | MECSAS, JOAN C | reporter.nih.gov |
| Metabolic control of normal and malignant hematopoiesis | NIH | National Cancer Institute | 2021 to 2025 | $2,869,404 | September 1, 2020 | May 31, 2027 | INTLEKOFER, ANDREW MICHAEL | reporter.nih.gov |
| WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,862,721 | September 10, 2021 | August 31, 2026 | LEE, BRENDAN | reporter.nih.gov |
| In Vivo Prevention of Murine GVHD | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,859,522 | July 1, 2022 | June 30, 2027 | BLAZAR, BRUCE R | reporter.nih.gov |
| Uncovering mechanisms of protection from Alzheimer's disease in CHIP using human cohorts and biosamples | NIH | National Institute on Aging | 2024 to 2025 | $2,857,034 | September 17, 2024 | May 31, 2029 | JAISWAL, SIDDHARTHA | reporter.nih.gov |
| Functional Determinants of Metastatic Dormancy | NIH | National Cancer Institute | 2021 to 2025 | $2,856,382 | January 12, 2022 | June 30, 2026 | AGUIRRE-GHISO, JULIO A. | reporter.nih.gov |
| Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases | NIH | National Institute on Aging | 2022 to 2025 | $2,847,875 | March 1, 2022 | December 31, 2026 | LIM, JANGHOO | reporter.nih.gov |
| Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers | NIH | National Cancer Institute | 2021 to 2025 | $2,839,105 | April 1, 2021 | March 31, 2027 | VINCI, CHRISTINE | reporter.nih.gov |
| Decoding LRH-1 Activity in Gut Regeneration and Differentiation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,837,160 | June 14, 2021 | April 30, 2026 | BAYRER, JAMES | reporter.nih.gov |
| DEFINING MECHANISMS OF PROGENITOR BALANCE AND NEURONAL CONNECTIVITY | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,836,728 | May 1, 2020 | April 30, 2028 | ANTON, EVA S | reporter.nih.gov |
| Dissecting the thermogenic adipose niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,835,733 | September 1, 2022 | August 31, 2026 | TSENG, YU-HUA | reporter.nih.gov |
| Developing gene therapy strategies to treat alpha thalassemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,821,947 | January 1, 2022 | December 31, 2025 | MACKENZIE, TIPPI | reporter.nih.gov |
| Production of Cultured Red Blood Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,816,822 | September 15, 2015 | March 31, 2029 | BOUHASSIRA, ERIC E. | reporter.nih.gov |
| The role of the intestinal microbiome in cancer immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $2,811,009 | August 1, 2023 | July 31, 2030 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,809,429 | July 10, 2019 | June 30, 2029 | BURDETTE, JOANNA E | reporter.nih.gov |
| Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation | NIH | National Cancer Institute | 2022 to 2025 | $2,804,127 | July 22, 2022 | June 30, 2027 | VALDIMARSDOTTIR, HEIDDIS | reporter.nih.gov |
| Cellular and molecular analysis of B lymphocyte development and selection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,800,489 | June 15, 2014 | April 30, 2030 | PEREIRA, JOAO | reporter.nih.gov |
| A premalignant chronology of cell-state variability in basal-like breast cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,790,901 | January 1, 2022 | December 31, 2026 | JANES, KEVIN A | reporter.nih.gov |
| Regulation of arterial phenotype by perivascular adipose tissue in cardiometabolic disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,788,828 | July 1, 2018 | June 30, 2027 | LIAW, LUCY | reporter.nih.gov |
| Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,784,762 | December 20, 2021 | November 30, 2026 | KARBOWNICZEK, MAGDALENA | reporter.nih.gov |
| Targeting vascular dysfunction to promote lung repair and fibrosis resolution | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,782,716 | March 5, 2022 | February 28, 2027 | LIGRESTI, GIOVANNI | reporter.nih.gov |
| Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,778,087 | July 1, 2022 | April 30, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Developmental Exposures, Stem Cell Reprogramming, and Breast Cancer Disparities | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,767,677 | January 1, 2018 | October 31, 2027 | COLACINO, JUSTIN ADAM | reporter.nih.gov |
| Mechanisms and Impact of Pregnancy-Induced Adaptations in Pelvic Floor Muscles | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,761,892 | August 1, 2017 | June 30, 2026 | ALPERIN, MARIANNA | reporter.nih.gov |
| Base-Edited Hematopoietic Stem and Progenitor Cells To Enable Safe Use Of Highly Potent CD33-Targeted Radioimmunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $2,758,516 | July 1, 2022 | June 30, 2027 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,754,807 | September 19, 2022 | June 30, 2027 | FARACH-CARSON, MARY C | reporter.nih.gov |
| Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors | NIH | National Cancer Institute | 2021 to 2025 | $2,750,972 | July 12, 2021 | June 30, 2027 | NGEN, ETHEL JOSO | reporter.nih.gov |
| In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,743,808 | January 10, 2023 | December 31, 2027 | LIEBER, ANDRE MICHAEL | reporter.nih.gov |
| Cadherin-Dependent Regulation of Satellite Cell Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,741,976 | July 15, 2016 | June 30, 2027 | KRAUSS, ROBERT S. | reporter.nih.gov |
| Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,726,409 | February 15, 2022 | January 31, 2026 | LANDAU, DAN | reporter.nih.gov |
| Mechanism of Matrix Gla Protein (MGP); Adipose Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,719,728 | April 24, 2006 | June 30, 2027 | BOSTROM, KRISTINA I | reporter.nih.gov |
| Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,717,504 | February 1, 2021 | December 31, 2026 | SMITH, LACHLAN JAMES | reporter.nih.gov |
| Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,714,234 | August 12, 2022 | July 31, 2027 | PONNUSAMY, MOORTHY P. | reporter.nih.gov |
| Development of the resident macrophage lineage in mouse and human | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,710,279 | February 8, 2017 | December 31, 2027 | GEISSMANN, FREDERIC | reporter.nih.gov |
| Regulation of T cell exhaustion via 3D chromatin architecture | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,704,065 | March 15, 2015 | April 30, 2030 | XUE, HAI-HUI | reporter.nih.gov |
| Mitochondrial Regulation of Hematopoietic Stem Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,703,143 | January 17, 2017 | December 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease | NIH | National Institute on Aging | 2024 to 2025 | $2,701,324 | September 1, 2024 | June 30, 2029 | BOLTON, KELLY LEIGH | reporter.nih.gov |
| New roles of endothelial regrowth in ischemic tissue recovery and regeneration | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,697,119 | April 1, 2022 | March 31, 2027 | KUME, TSUTOMU | reporter.nih.gov |
| Regulation of DNA methylation by TETs and QSER1 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,694,857 | September 22, 2022 | August 31, 2027 | EVANS, TODD R | reporter.nih.gov |
| Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $2,690,224 | August 1, 2021 | July 31, 2027 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| Understanding the impact of Clusterin on the oligodendrocyte lineage in AD | NIH | National Institute on Aging | 2022 to 2025 | $2,688,657 | September 15, 2022 | August 31, 2027 | GAULTIER, ALBAN P | reporter.nih.gov |
| Clinical Significance of MHC Haplotypes in HCT | NIH | National Cancer Institute | 2021 to 2025 | $2,687,420 | March 1, 2003 | August 31, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,684,733 | August 1, 2024 | May 31, 2027 | GILKESON, GARY S | reporter.nih.gov |
| Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia. | NIH | National Cancer Institute | 2022 to 2025 | $2,677,641 | August 1, 2022 | July 31, 2027 | STIEGLITZ, ELLIOT | reporter.nih.gov |
| Intraventricular Hemorrhage Disrupts the Blood Brain Barrier in Premature Infants | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,672,389 | March 1, 2021 | February 28, 2026 | BALLABH, PRAVEEN | reporter.nih.gov |
| Hematopoietic and Immune Development in the Human Chorion | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,664,107 | April 11, 2022 | March 31, 2027 | MUENCH, MARCUS O | reporter.nih.gov |
| The Molecular Regulatory Mechanism of Tooth Root Development | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,659,844 | July 19, 2012 | April 30, 2029 | CHAI, YANG | reporter.nih.gov |
| Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations | NIH | National Cancer Institute | 2022 to 2025 | $2,657,718 | June 15, 2022 | May 31, 2027 | PAPAPETROU, EIRINI | reporter.nih.gov |
| Autoimmune Stem-like CD8 T cells in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,657,421 | June 8, 2023 | May 31, 2028 | SCHIETINGER, ANDREA | reporter.nih.gov |
| Studies of the fate of the osteoclast | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,655,069 | June 1, 1995 | December 31, 2026 | BOYCE, BRENDAN F | reporter.nih.gov |
| Mechanisms of Hedgehog signaling in glioblastoma | NIH | National Cancer Institute | 2021 to 2025 | $2,642,438 | July 1, 2021 | April 30, 2026 | RALEIGH, DAVID R | reporter.nih.gov |
| Regulation of macrophage metabolism in aged muscle during recovery | NIH | National Institute on Aging | 2022 to 2025 | $2,642,202 | May 15, 2022 | April 30, 2027 | DRUMMOND, MICAH J | reporter.nih.gov |
| Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,636,174 | July 13, 2022 | April 30, 2027 | PARK, DONGSU | reporter.nih.gov |
| Stress and Human Stem/Progenitor Cells: Biobehavioral Mechanisms | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,635,227 | August 15, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| Novel targeted therapy for treating Ovarian Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,633,406 | August 1, 2022 | July 31, 2027 | VADLAMUDI, RATNA K | reporter.nih.gov |
| Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy | NIH | National Cancer Institute | 2022 to 2025 | $2,633,070 | September 1, 2022 | August 31, 2027 | HUANG, ALEXANDER | reporter.nih.gov |
| Triglycerides as a Predictor of Newborn Subcutaneous and Liver Fat: Contributors to Fetal Fat Accretion in Obese Pregnancies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,620,225 | May 7, 2021 | March 31, 2027 | BARBOUR, LINDA ANNE | reporter.nih.gov |
| Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,617,623 | June 1, 2022 | March 31, 2027 | SAHIN, ERGUN | reporter.nih.gov |
| Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,608,897 | August 15, 2022 | May 31, 2027 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Transcriptional networks establishing the precise gene expression states that define neurosensory cell identity in the inner ear | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,603,881 | February 1, 2016 | June 30, 2027 | XU, PIN-XIAN | reporter.nih.gov |
| Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,603,837 | August 1, 2022 | June 30, 2027 | LI, CHUN | reporter.nih.gov |
| Cell fate choices by Tbx1 in forming the mammalian heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,603,457 | August 20, 2020 | April 30, 2029 | MORROW, BERNICE E | reporter.nih.gov |
| Genetic Regulatory Network in Craniofacial Development | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,599,984 | March 12, 2025 | January 31, 2030 | HSU, WEI | reporter.nih.gov |
| Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis | NIH | National Cancer Institute | 2022 to 2025 | $2,594,306 | January 14, 2011 | December 31, 2026 | MERAD, MIRIAM | reporter.nih.gov |
| An Interneuron-based Cell Therapy for Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,589,602 | September 1, 2010 | March 31, 2027 | BARABAN, SCOTT C | reporter.nih.gov |
| Development of a stem-cell derived thymic cell therapy to treat patients with athymia | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,586,728 | April 15, 2022 | January 31, 2027 | LIM, BING | reporter.nih.gov |
| Heterogeneity of Satellite Cell Populations Play a Role in Improvements in PAD after Exercise Therapy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,586,669 | February 15, 2022 | January 31, 2027 | HANSEN, LAURA MARIE | reporter.nih.gov |
| Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,584,743 | April 1, 2022 | August 31, 2026 | LIBBY, PETER | reporter.nih.gov |
| Microribbon scaffold-mediated Immunomodulation for Cranial Bone Repair | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,582,020 | January 1, 2015 | May 31, 2027 | YANG, FAN | reporter.nih.gov |
| ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism | NIH | National Cancer Institute | 2022 to 2025 | $2,576,142 | January 1, 2022 | April 30, 2027 | SHUREIQI, IMAD | reporter.nih.gov |
| Modeling Normal and Abnormal Trophoblasts | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,565,353 | September 25, 2018 | March 31, 2028 | SCHULZ, LAURA CLAMON | reporter.nih.gov |
| Regulation of catagen regression and progenitor pruning by the dermal sheath | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,565,274 | July 1, 2021 | June 30, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Bioinspired Mechanically Stiff Hydrogels for Osteochondral Tissue Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,563,338 | July 25, 2016 | March 31, 2027 | BRYANT, STEPHANIE J | reporter.nih.gov |
| Mechanisms for Regenerative Healing in Intervertebral Discs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,560,545 | January 15, 2022 | December 31, 2026 | IATRIDIS, JAMES C. | reporter.nih.gov |
| Defining the mechanisms regulating adipose tissue metabolic memory and its role in rebound weight gain. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,559,138 | September 7, 2025 | August 31, 2029 | MERRICK, DAVID MICHAEL | reporter.nih.gov |
| Multimodal Optical Imaging on the Effect of Maternal Polysubstance Exposure on Fetal Brain Microvessel Function | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,556,302 | January 1, 2016 | July 31, 2027 | LARIN, KIRILL V | reporter.nih.gov |
| Membrane protein target for leukemia therapy | NIH | National Cancer Institute | 2021 to 2025 | $2,553,914 | September 1, 2020 | July 31, 2027 | KANG, XUNLEI | reporter.nih.gov |
| Mechanisms underlying extracellular vesicle mediated changes in inflammation, neural circuitry and plasticity following cortical injury in aged monkeys | NIH | National Institute on Aging | 2022 to 2025 | $2,553,369 | July 15, 2022 | June 30, 2027 | MOORE, TARA L | reporter.nih.gov |
| MECHANISMS OF CHIEF CELL DEDIFFERENTIATION | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,549,088 | September 30, 2015 | June 30, 2029 | MILLS, JASON C | reporter.nih.gov |
| Mechanisms of lineage plasticity revealed by YY1 deficiency. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,544,568 | June 1, 2021 | May 31, 2026 | ATCHISON, MICHAEL LEE | reporter.nih.gov |
| Intestinal tissue intrinsic mechanisms in regulation of GI GVHD | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,544,373 | June 13, 2022 | May 31, 2027 | REDDY, PAVAN | reporter.nih.gov |
| CTL-killing capacity and cancer stiffness in cancer immunity and therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,544,012 | January 7, 2022 | December 31, 2026 | ZOU, WEIPING | reporter.nih.gov |
| Hair Follicle Dermal Stem Cell Functions and Potential | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,543,600 | July 8, 2021 | June 30, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Mechanisms of Hematopoietic Stem Cell and Blood aging | NIH | National Institute on Aging | 2021 to 2025 | $2,543,077 | September 15, 2021 | May 31, 2027 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| The Role of Ceramides in the Intestinal Stem Cell | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,539,916 | September 23, 2021 | May 31, 2026 | SUMMERS, SCOTT A | reporter.nih.gov |
| Impact of Clonal Hematopoiesis on the Progression of Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,534,528 | April 20, 2022 | March 31, 2026 | ROBINSON-COHEN, CASSIANNE | reporter.nih.gov |
| Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes | NIH | National Institute on Aging | 2023 to 2025 | $2,529,608 | April 1, 2023 | March 31, 2028 | TCW, JULIA | reporter.nih.gov |
| Postnatal mechanisms of cognitive development in mice | NIH | National Institute of Mental Health | 2022 to 2025 | $2,527,800 | January 18, 2013 | April 30, 2027 | HIROI, NOBORU | reporter.nih.gov |
| Mechanisms of prenatal opioid exposure on brain and behavior | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,525,552 | July 1, 2022 | April 30, 2027 | WU, PING | reporter.nih.gov |
| Dissecting innate immune signaling in pre-leukemia evolution | NIH | National Cancer Institute | 2022 to 2025 | $2,523,046 | March 4, 2022 | February 28, 2027 | STARCZYNOWSKI, DANIEL | reporter.nih.gov |
| NEDD9 and Chromium(VI) Carcinogenesis | NIH | National Institute of Environmental Health Sciences | 2025 | $2,518,755 | September 16, 2025 | September 15, 2029 | COSTA, MAX | reporter.nih.gov |
| Dysfunctional skeletal muscle communication in arsenic-promoted cardiometabolic disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,513,851 | July 23, 2021 | June 30, 2026 | BARCHOWSKY, AARON | reporter.nih.gov |
| Systems Biology of Glycosylation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,507,240 | September 5, 2011 | January 31, 2027 | NEELAMEGHAM, SRIRAM | reporter.nih.gov |
| Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,501,570 | July 8, 2021 | June 30, 2027 | YAO, CHEN | reporter.nih.gov |
| Targeting eIF4A1 in drug-resistant breast cancer stem-like cells | NIH | National Cancer Institute | 2022 to 2025 | $2,500,438 | August 9, 2022 | July 31, 2027 | RAMAN, DAYANIDHI | reporter.nih.gov |
| A Hydrogel-Based Cellular Model of the Human Vocal Fold | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,498,414 | December 1, 2015 | March 31, 2027 | JIA, XINQIAO | reporter.nih.gov |
| Role of Fbxw7-Mediated Proteasomal Degradation in Myofibers in Determining Muscle Stem Cell Pool Size | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,494,858 | July 1, 2020 | December 31, 2026 | SACCO, ALESSANDRA | reporter.nih.gov |
| The role of PHF6 in the control of hematopoietic stem cell aging. | NIH | National Institute on Aging | 2021 to 2025 | $2,490,000 | September 1, 2021 | May 31, 2027 | PALOMERO, TERESA | reporter.nih.gov |
| MG53 function in muscle aging | NIH | National Institute on Aging | 2022 to 2025 | $2,487,828 | September 30, 2022 | June 30, 2027 | MA, JIANJIE | reporter.nih.gov |
| Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,484,708 | May 12, 2022 | April 30, 2027 | MORROW, BERNICE E | reporter.nih.gov |
| The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,483,404 | July 1, 2023 | June 30, 2028 | CROOKS, GAY M | reporter.nih.gov |
| Role of lncRNA mediated R-loops in CTCF boundary function and AML genome organization | NIH | National Cancer Institute | 2022 to 2025 | $2,477,191 | December 3, 2021 | November 30, 2026 | HUANG, SUMING | reporter.nih.gov |
| Trimodal Vitality Imaging of Neural Progenitor Cells in the Spinal Cord | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,476,665 | August 1, 2020 | April 30, 2027 | EMELIANOV, STANISLAV Y | reporter.nih.gov |
| NEDD4 in right ventricular development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,473,604 | September 1, 2021 | August 31, 2026 | FANG, XI | reporter.nih.gov |
| Hormetic ER Stress Regulation of Hematopoietic Stem Cell Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,466,695 | July 3, 2021 | May 31, 2026 | LUCHSINGER, LARRY L | reporter.nih.gov |
| Deciphering multi-scale differentiation and patterning cues driving whole craniofacial joint regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,462,001 | September 6, 2022 | August 31, 2027 | SMEETON, JOANNA MARJORIE | reporter.nih.gov |
| An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,460,707 | February 15, 2021 | January 31, 2027 | ZHAO, MINGTAO | reporter.nih.gov |
| Molecular Determinants of Inflammatory Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,460,561 | September 20, 2021 | August 31, 2026 | DEVI, GAYATHRI | reporter.nih.gov |
| Mechanisms of granulocyte homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,456,642 | July 1, 2015 | April 30, 2029 | GRIMES, H. LEIGHTON | reporter.nih.gov |
| Pathogenesis of Airway Stem Cell Abnormalities in Obliterative Bronchiolitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,452,366 | April 1, 2019 | January 31, 2029 | PAREKH, KALPAJ RAJNIKANT | reporter.nih.gov |
| Adenylate Kinase 2 Deficiency and the Failure of Myelopoiesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,449,815 | April 1, 2022 | March 31, 2027 | WEINACHT, KATJA GABRIELE | reporter.nih.gov |
| Control of GVHD by Probiotics with individual Commensal Bacteria | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,448,717 | May 5, 2022 | April 30, 2027 | YU, XUE-ZHONG | reporter.nih.gov |
| Targeting jmjd3 mitigates heterotopic ossification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,447,255 | July 1, 2021 | December 31, 2026 | GALLAGHER, KATHERINE ANN | reporter.nih.gov |
| Metabolic reprogramming of Alveolar Type 2 cells in response to lung injury | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,446,943 | July 1, 2022 | September 30, 2026 | GUTTENTAG, SUSAN H. | reporter.nih.gov |
| REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,446,210 | September 11, 2012 | April 30, 2028 | MILLS, JASON C | reporter.nih.gov |
| Biology and novel therapy of AML expressing somatic or germline mutant RUNX1 | NIH | National Cancer Institute | 2021 to 2025 | $2,439,831 | December 1, 2020 | November 30, 2025 | BHALLA, KAPIL | reporter.nih.gov |
| Genomic tools for massively parallel recording of signaling activity at cellular resolution in a brain-wide manner | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,437,500 | September 22, 2022 | August 31, 2027 | RAJ, BUSHRA | reporter.nih.gov |
| Functional long noncoding RNAs in neural development | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,437,149 | July 1, 2022 | June 30, 2027 | LIM, DANIEL A | reporter.nih.gov |
| Mechanisms of Epigenetic Plasticity in PDAC | NIH | National Cancer Institute | 2021 to 2025 | $2,434,090 | April 1, 2021 | March 31, 2027 | YI, CHUNLING | reporter.nih.gov |
| Mechanisms that regulate erythroid differentiation of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,434,029 | July 1, 2022 | June 30, 2027 | NAKADA, DAISUKE | reporter.nih.gov |
| Mechanisms by which effector T cells modulate endogenous remyelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,434,021 | July 1, 2000 | November 30, 2026 | CALABRESI, PETER A | reporter.nih.gov |
| Molecular and anatomical atlases from progenitors to adult neurons in the mouse spinal cord | NIH | National Institute of Mental Health | 2024 to 2025 | $2,433,284 | March 1, 2024 | November 30, 2026 | LAI, HELEN | reporter.nih.gov |
| Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,428,878 | September 12, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| In vivo Monitoring of Neutrophil Function in Patients after Stem Cell Transplant | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,426,537 | February 13, 2023 | January 31, 2028 | IRIMIA, DANIEL | reporter.nih.gov |
| Allorecognition, parasitic stem cells and regeneration in a basal chordate | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,424,717 | January 1, 2021 | December 31, 2026 | DE TOMASO, ANTHONY W | reporter.nih.gov |
| Progenitor Cells for High Endothelium in the Immune Response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,423,970 | September 25, 2017 | April 30, 2028 | BUTCHER, EUGENE C | reporter.nih.gov |
| Photoresponsive materials to study matricellular signaling dynamics during crypt formation and fission | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,423,541 | August 1, 2019 | April 30, 2028 | ANSETH, KRISTI S. | reporter.nih.gov |
| Targeting stem-like cells and their niche in pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,423,178 | January 1, 2025 | December 31, 2026 | TAMMELA, TUOMAS | reporter.nih.gov |
| Molecular Genetics of the Telomere Biology Disorders | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,421,352 | May 15, 2016 | June 30, 2026 | BERTUCH, ALISON A | reporter.nih.gov |
| Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,419,460 | February 7, 2022 | November 30, 2026 | IAKOUCHEVA, LILIA M | reporter.nih.gov |
| Mechanism of white matter pathology in Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $2,417,841 | February 1, 2022 | November 30, 2026 | QI, XIN | reporter.nih.gov |
| Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology | NIH | National Cancer Institute | 2023 to 2025 | $2,416,050 | September 7, 2023 | August 31, 2028 | CHI, HONGBO | reporter.nih.gov |
| Catalytic roles of RNA methyltransferase DIMT1 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,415,754 | July 1, 2022 | June 30, 2027 | LIU, FANGE | reporter.nih.gov |
| Innate immune response signaling in cardiac injury healing | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,408,533 | January 1, 2022 | December 31, 2026 | MOLKENTIN, JEFFERY D | reporter.nih.gov |
| Basal cells in airway and alveolar remodeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,407,737 | May 1, 2022 | April 30, 2026 | STRIPP, BARRY R | reporter.nih.gov |
| The role of TGFβs and cFAPs in Cardiac Pathology from RNA Toxicity | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,404,853 | July 1, 2023 | May 31, 2027 | MAHADEVAN, MANI SUBRAMANIAM | reporter.nih.gov |
| Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,402,918 | July 15, 2021 | April 30, 2026 | LEVI, BENJAMIN | reporter.nih.gov |
| Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2025 | $2,401,768 | July 9, 2021 | June 30, 2026 | CALIGIURI, MICHAEL A | reporter.nih.gov |
| Image-guided intra-arterial administration of antibody-releasing glial progenitors to control the HIV CNS reservoir. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,399,095 | September 1, 2022 | June 30, 2027 | WALCZAK, PIOTR | reporter.nih.gov |
| Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,398,824 | May 1, 2022 | April 30, 2030 | LATHIA, JUSTIN D. | reporter.nih.gov |
| ROLE OF RNA SEQUESTRATION IN ACUTE MYELOID LEUKEMIA | NIH | National Cancer Institute | 2025 | $2,398,360 | August 15, 2025 | July 31, 2029 | DI STEFANO, BRUNO | reporter.nih.gov |
| Roles of Gsx factors in basal ganglia development | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,397,818 | January 1, 2022 | December 31, 2026 | CAMPBELL, KENNETH J | reporter.nih.gov |
| Clonal hematopoiesis, mild cognitive impairment and kidney function decline | NIH | National Institute on Aging | 2022 to 2025 | $2,396,339 | June 1, 2022 | March 31, 2027 | CHONCHOL, MICHEL BENJAMIN | reporter.nih.gov |
| Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,392,495 | March 1, 2021 | January 31, 2027 | NAYAK, JAYAKAR V | reporter.nih.gov |
| Transcription Factor Control of Neuronal Diversity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,391,401 | April 1, 2022 | January 31, 2027 | JOHNSON, JANE E | reporter.nih.gov |
| Promoting T cell reconstitution after hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,391,092 | January 1, 2024 | December 31, 2030 | DUDAKOV, JARROD | reporter.nih.gov |
| HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,390,244 | January 13, 2023 | December 31, 2026 | HENRICH, TIMOTHY JENSEN | reporter.nih.gov |
| IBIS-iPSC: Organoid modeling of cortical surface area hyperexpansion in autism spectrum disorder | NIH | National Institute of Mental Health | 2023 to 2025 | $2,389,134 | April 1, 2023 | January 31, 2028 | STEIN, JASON LOUIS | reporter.nih.gov |
| STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,388,852 | March 20, 2022 | December 31, 2026 | OHM, JOYCE ELLEN | reporter.nih.gov |
| Hematopoietic Regulation via GATA Switches | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,385,213 | February 1, 2006 | November 30, 2029 | BRESNICK, EMERY H. | reporter.nih.gov |
| Mechanisms of Neural Stem Cell Mechanoregulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,383,261 | May 1, 2012 | April 30, 2027 | SCHAFFER, DAVID V | reporter.nih.gov |
| Decode Mitochondrial Morphology Dynamics to Predict Cell Fate Decisions | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,379,500 | September 8, 2022 | August 31, 2027 | SCHOENEBERG, JOHANNES | reporter.nih.gov |
| Cxcl12-Hedgehog signaling in cranial bone regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,375,113 | July 5, 2016 | June 30, 2027 | YANG, YINGZI | reporter.nih.gov |
| Transcriptional Control of Hemoglobin Synthesis and Erythrocyte Development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,373,082 | July 16, 1996 | May 31, 2026 | BRESNICK, EMERY H. | reporter.nih.gov |
| REGULATORS OF EPIDERMAL GENE EXPRESSION | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,368,660 | February 27, 1999 | November 30, 2029 | KHAVARI, PAUL | reporter.nih.gov |
| Regulation and manipulation of the telomerase RNA component in hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,367,468 | December 1, 2015 | May 14, 2026 | AGARWAL, SUNEET | reporter.nih.gov |
| Discoidin Domain Receptor 2, β1 Integrins and ECM Control of Bone Formation | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,366,359 | March 12, 2021 | August 31, 2026 | FRANCESCHI, RENNY THEODORE | reporter.nih.gov |
| Cellular mechanisms by which exhausted T cell responses are restored | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,361,598 | March 1, 2017 | July 31, 2027 | MEMPEL, THORSTEN ROMAN | reporter.nih.gov |
| Clonal hematopoiesis and inherited genetic variation in sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,361,205 | April 1, 2023 | March 31, 2027 | BICK, ALEXANDER | reporter.nih.gov |
| CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,357,715 | September 22, 2022 | August 31, 2027 | BONGARZONE, ERNESTO ROQUE | reporter.nih.gov |
| Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,356,758 | August 22, 2022 | July 31, 2027 | WU, TUOQI | reporter.nih.gov |
| DNMT3A in Development of Hematologic Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $2,354,394 | September 11, 2014 | November 30, 2029 | GOODELL, MARGARET A. | reporter.nih.gov |
| 3D Bioprinted Spinal Cord Organoids as a Relay System for Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,352,214 | September 2, 2021 | June 30, 2026 | PARR, ANN M | reporter.nih.gov |
| Intermittent fasting restores salivary gland function in Sjögren’s syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,348,947 | March 3, 2021 | February 28, 2027 | ZHOU, JING | reporter.nih.gov |
| Replicative Potential of Muscle Stem Cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,347,486 | August 17, 2017 | July 31, 2027 | OLWIN, BRADLEY B | reporter.nih.gov |
| Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,346,523 | May 1, 2021 | April 30, 2027 | KOGUT, IGOR | reporter.nih.gov |
| Retinal sheet transplant impact on functional organization of visual cortex in retinal degenerate animal models | NIH | National Eye Institute | 2022 to 2025 | $2,340,862 | May 1, 2022 | March 31, 2027 | LYON, DAVID C | reporter.nih.gov |
| 3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,339,586 | June 18, 2021 | May 31, 2027 | RAVINDRAN, SRIRAM | reporter.nih.gov |
| Molecular basis and protective efficacy of cross-neutralizing antibodies against four major respiratory viruses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,206 | March 16, 2023 | February 29, 2028 | BOONYARATANAKORNKIT, JIM | reporter.nih.gov |
| Chromatin Dynamics and Genome Regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,335,578 | August 4, 2017 | May 31, 2027 | BANASZYNSKI, LAURA | reporter.nih.gov |
| Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging | NIH | National Cancer Institute | 2023 to 2025 | $2,335,453 | July 1, 2023 | June 30, 2028 | KESHARI, KAYVAN R | reporter.nih.gov |
| The Synthetic Kidney: A Revolutionary Solution for the Shortage of Kidneys for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,335,138 | September 15, 2022 | August 31, 2027 | LI, ZHONGWEI | reporter.nih.gov |
| Multi-Tissue Craniofacial Engineering using 3D-BMP9-Notch-Synergized Graphene Citrate Composite Scaffolds | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,334,479 | April 1, 2021 | January 31, 2027 | REID, RUSSELL R. | reporter.nih.gov |
| Chemotherapy-free cure of hemoglobin disorders through base editing | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,334,252 | September 1, 2023 | May 31, 2027 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Regulators of epidermal growth and differentiation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,334,246 | February 17, 2015 | June 30, 2026 | SEN, GEORGE L | reporter.nih.gov |
| Role and Regulation of Cellular Polarity in Craniofacial Skeletogenesis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,330,991 | April 1, 2001 | September 22, 2028 | SCHILLING, THOMAS F | reporter.nih.gov |
| The Biology of Stem Cells in the Human Parasite Schistosoma Mansoni | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,328,971 | February 1, 2016 | January 31, 2026 | COLLINS, JAMES J | reporter.nih.gov |
| Immuno-Cell Therapy for Brain Tumors | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,328,113 | January 1, 2022 | December 31, 2026 | BREAKEFIELD, XANDRA OWENS | reporter.nih.gov |
| Metabolic Regulation of Glioblastoma Epitranscriptomics | NIH | National Cancer Institute | 2022 to 2025 | $2,327,158 | July 7, 2022 | June 30, 2027 | AGNIHOTRI, SAMEER | reporter.nih.gov |
| ABCB5-positive stem cells for LSCD therapy | NIH | National Eye Institute | 2023 to 2025 | $2,325,074 | June 1, 2016 | May 31, 2028 | FRANK, MARKUS H. | reporter.nih.gov |
| Nutrient-dependent regulation of neural stem cell proliferation and neural circuit formation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,324,951 | July 1, 2021 | June 30, 2027 | SIEGRIST, SARAH ELIZABETH | reporter.nih.gov |
| Bottom-Up Assembly of Functional Salivary Gland Tissues | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,324,071 | May 1, 2021 | January 31, 2027 | JIA, XINQIAO | reporter.nih.gov |
| Dynamic ECM-Mimicking Biomaterials for Ischemia Treatment | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,323,983 | December 15, 2021 | November 30, 2026 | ZOLDAN, JANETA | reporter.nih.gov |
| Cell Fate Regulation in Esophageal Progenitor Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,322,436 | April 1, 2022 | March 31, 2027 | QUE, JIANWEN | reporter.nih.gov |
| Physiological Dissection of the Mevalonate Pathway | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,317,098 | April 6, 2020 | February 28, 2030 | LAGOR, WILLIAM RAYMOND | reporter.nih.gov |
| Control of bone physiology by a novel type of adipose cells | NIH | National Institute on Aging | 2021 to 2025 | $2,313,640 | May 15, 2021 | February 28, 2027 | QIN, LING | reporter.nih.gov |
| Derivation of pancreatic islet-like organoids from human gastric stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,313,256 | August 24, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| Role of Cholecystokinin in the Dentate Gyrus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,307,005 | June 1, 2021 | March 31, 2027 | SONG, JUAN | reporter.nih.gov |
| Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,306,170 | July 1, 2022 | April 30, 2027 | GOUON-EVANS, VALERIE B | reporter.nih.gov |
| Neural Stem Cell-derived EVs for Improving Aged Brain Function | NIH | National Institute on Aging | 2022 to 2025 | $2,306,114 | August 1, 2022 | April 30, 2027 | SHETTY, ASHOK K | reporter.nih.gov |
| How Patterned Mesenchymal-Epithelial interactions Shape Intestinal Crypts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,304,272 | February 15, 2022 | January 31, 2026 | KLEIN, OPHIR D | reporter.nih.gov |
| IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,303,969 | January 1, 2022 | June 30, 2026 | PACZESNY, SOPHIE | reporter.nih.gov |
| Distinct roles of chromatin regulation in transcriptome and genome maintenance in corticogenesis | NIH | National Institute of Mental Health | 2022 to 2025 | $2,297,766 | September 1, 2022 | June 30, 2027 | KWAN, KENNETH YU-CHUNG | reporter.nih.gov |
| The regulation of melanocyte stem cells by Wnt signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,297,460 | August 5, 2011 | July 31, 2026 | ITO, MAYUMI | reporter.nih.gov |
| Glial HIFa: mechanisms and implications in hypoxia/ischemia-induced oligodendroglial pathology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,296,042 | May 1, 2021 | February 28, 2027 | GUO, FUZHENG | reporter.nih.gov |
| Tracing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,295,485 | January 15, 2021 | January 31, 2026 | HORMOZ, SAHAND | reporter.nih.gov |
| Thymic selection abnormalities in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,291,187 | June 26, 2023 | May 31, 2028 | SYKES, MEGAN | reporter.nih.gov |
| Defining the impact of stromal aging on ovarian cancer initiation | NIH | National Institute on Aging | 2021 to 2025 | $2,289,174 | September 30, 2021 | May 31, 2027 | COFFMAN, LAN | reporter.nih.gov |
| Molecular mechanism underlying clonal expansion of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,288,832 | July 15, 2019 | March 31, 2028 | LIU, YAN | reporter.nih.gov |
| Regulation of astrocyte diversity in the cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,287,542 | August 1, 2021 | June 30, 2027 | KORDULA, TOMASZ K | reporter.nih.gov |
| Biomechanical Determinants of Hematopoietic Stem Cell Potential | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,282,783 | January 15, 2018 | November 30, 2026 | WENZEL, PAMELA LYNN | reporter.nih.gov |
| The role of EZH1 in neuronal differentiation and neurological disorders | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,282,077 | May 5, 2022 | April 30, 2027 | AKIZU, NAIARA | reporter.nih.gov |
| Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model | NIH | National Cancer Institute | 2021 to 2025 | $2,268,156 | March 1, 2021 | February 28, 2026 | GROSSHANS, DAVID R | reporter.nih.gov |
| Deciphering gene regulatory networks modulating human trophoblast stem cell self-renewal and differentiation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,266,651 | April 1, 2021 | February 28, 2027 | KIM, JONGHWAN | reporter.nih.gov |
| Tapeworm stem cells as drivers of regeneration and reproduction | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,265,000 | March 5, 2021 | February 28, 2027 | ROZARIO, TANIA | reporter.nih.gov |
| Biostimulatory nanofiber-hydrogel composite for soft tissue remodeling | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,263,220 | February 1, 2022 | January 31, 2027 | REDDY, SASHANK K | reporter.nih.gov |
| Exploring networks underlying muscle stem cell identity - Resubmission - 1 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,259,735 | June 1, 2021 | May 31, 2027 | DYNLACHT, BRIAN D | reporter.nih.gov |
| High resolution lineage tracing of developmental hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,256,385 | May 5, 2023 | February 28, 2027 | CAMARGO, FERNANDO | reporter.nih.gov |
| The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia | NIH | National Cancer Institute | 2022 to 2025 | $2,254,307 | March 1, 2022 | February 28, 2027 | CHEN, JIANJUN | reporter.nih.gov |
| Harnessing Platelet-Endothelial Interactions for Exosome Delivery | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,253,989 | April 1, 2019 | July 31, 2027 | CHENG, KE | reporter.nih.gov |
| The selective advantage of mismatch repair loss in colonic stem cells | NIH | National Cancer Institute | 2021 to 2025 | $2,253,508 | April 1, 2021 | March 31, 2027 | HEINEN, CHRISTOPHER D. | reporter.nih.gov |
| Mechanisms of cell fate specification by glycosylation | NIH | National Institute of General Medical Sciences | 2025 | $2,252,479 | September 1, 2025 | July 31, 2029 | KASPER, DIONNA | reporter.nih.gov |
| Phylodynamics of Cell Populations | NIH | National Institute of General Medical Sciences | 2025 | $2,252,479 | September 1, 2025 | August 31, 2029 | HOEHN, KENNETH | reporter.nih.gov |
| Regulation and functional contribution of hypothalamic modified adult hippocampal neurogenesis | NIH | National Institute of Mental Health | 2023 to 2025 | $2,252,272 | July 6, 2023 | April 30, 2026 | SONG, JUAN | reporter.nih.gov |
| Elucidating the roles of alveolar macrophage inflammation and self renewal during influenza infection | NIH | National Institute on Aging | 2021 to 2025 | $2,252,254 | August 15, 2020 | April 30, 2030 | SUN, JIE | reporter.nih.gov |
| Emergency Myelopoiesis in the Control of Blood Production | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,251,896 | April 1, 2024 | March 31, 2031 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| A stem cell activated cryogel bioscaffold that restores islet bioenergetics while providing oxygen and nutrients at extravascular sites of transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,251,861 | April 1, 2022 | March 31, 2027 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Mechanisms of Telomere-Mediated Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,251,236 | July 10, 2018 | June 30, 2028 | ALDER, JONATHAN K. | reporter.nih.gov |
| Probing Tissue Heterogeneity and Stem Cell Niche with Micro-Organospheres | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,251,002 | April 1, 2017 | August 31, 2028 | SHEN, XILING | reporter.nih.gov |
| Epigenetic mechanisms of inflammatory memory propagation in human airway epithelia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,249,254 | May 5, 2022 | January 31, 2027 | PEZZULO, ALEJANDRO ANTONIO | reporter.nih.gov |
| Nutrient fuel preference, obesity, and stem cell lineage physiology | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,248,336 | August 16, 2021 | July 31, 2026 | DRUMMOND-BARBOSA, DANIELA | reporter.nih.gov |
| Molecular mechanisms driving mesenchymal colorectal cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,244,982 | March 17, 2021 | February 28, 2026 | MOSCAT, JORGE | reporter.nih.gov |
| Defining Protective CMV Immunity after Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,244,070 | February 6, 2023 | January 31, 2028 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Identifying the RNA Splicing and Gene Expression Changes that Cause Congenital Myotonic Dystrophy (Renewal) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,243,012 | April 1, 2018 | July 31, 2029 | JOHNSON, NICHOLAS ELWOOD | reporter.nih.gov |
| Brain development phenotyping of IMPC lethal mutant mice | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,240,058 | September 1, 2020 | June 30, 2026 | DWYER, NOELLE D | reporter.nih.gov |
| Molecular mechanisms mediating the soft tissue attachment to teeth | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,238,127 | February 20, 2023 | January 31, 2028 | HELMS, JILL A | reporter.nih.gov |
| A Clinical Indications Prediction (CLIP) Scale for Human Mesenchymal Stem Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,229,731 | September 1, 2018 | February 29, 2028 | PHINNEY, DONALD G | reporter.nih.gov |
| Temporal and Spatial Control of Oligodendrocyte Fate Specification | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,228,639 | July 1, 2022 | May 31, 2027 | FRANCO, SANTOS JOE | reporter.nih.gov |
| Regulation of the tuft-ILC2 circuit in the small intestine | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,224,205 | March 1, 2022 | February 28, 2027 | VON MOLTKE, JAKOB H. | reporter.nih.gov |
| Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $2,223,749 | December 1, 2020 | November 30, 2025 | SCHOBER, MARKUS | reporter.nih.gov |
| Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,221,837 | May 2, 2022 | April 30, 2027 | NGUYEN, KYTAI TRUONG | reporter.nih.gov |
| Effects of chronic pubertal stressors on mammary gland biology and cancer risk | NIH | National Cancer Institute | 2021 to 2025 | $2,220,324 | July 1, 2020 | June 30, 2027 | BRADY, MATTHEW J | reporter.nih.gov |
| Deciphering the role of p16INK4A+ fibroblasts in lung fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,216,263 | February 1, 2022 | November 30, 2025 | PENG, TIEN | reporter.nih.gov |
| Notch signaling and Bone Fracture Healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,213,436 | February 1, 2011 | January 31, 2027 | KALAJZIC, IVO | reporter.nih.gov |
| Post-TB epigenetic scars' impact on long-term inflammation, immunity and mortality | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,213,177 | July 1, 2023 | June 30, 2028 | DINARDO, ANDREW R | reporter.nih.gov |
| Asymmetric Cell Division of Vertebrate Radial Glia Neural Progenitors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,212,624 | May 1, 2021 | April 30, 2027 | GUO, SU | reporter.nih.gov |
| Progenitor cell states contributing to aging and lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,206,534 | September 24, 2021 | August 31, 2026 | HAIGIS, MARCIA | reporter.nih.gov |
| Comparison of normal aging with Alzheimer's Disease: cellular, synaptic, and vascular indices affecting brain plasticity and neurogenesis | NIH | National Institute on Aging | 2023 to 2025 | $2,205,002 | September 21, 2023 | May 31, 2028 | DUPONT, MAURA BOLDRINI | reporter.nih.gov |
| Mineralized collagen composite to accelerate craniofacial bone regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,203,403 | May 3, 2021 | April 30, 2027 | HARLEY, BRENDAN A. | reporter.nih.gov |
| Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | NIH | National Cancer Institute | 2022 to 2025 | $2,202,507 | March 1, 2022 | January 31, 2027 | ZAKRZEWSKI, JOHANNES | reporter.nih.gov |
| Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,201,577 | July 1, 2021 | June 30, 2026 | KARNOUB, ANTOINE ELIAS | reporter.nih.gov |
| Role of heat shock transcription factor HSF1 in tumorigenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,193,704 | July 1, 1996 | January 31, 2027 | MIVECHI, NAHID F | reporter.nih.gov |
| Develop age-relevant glial cellular models using human directly reprogrammed cells | NIH | National Institute on Aging | 2021 to 2025 | $2,191,200 | September 30, 2021 | May 31, 2027 | SHI, YANHONG | reporter.nih.gov |
| Dissecting the canonical and non-canonical functions of Tet2 in hematopoietic stem cells and hematologic disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,190,927 | July 1, 2019 | December 31, 2028 | ITO, KEISUKE | reporter.nih.gov |
| Promoting regenerative repair of aged cartilage | NIH | National Institute on Aging | 2023 to 2025 | $2,189,662 | May 15, 2023 | January 31, 2028 | COLLINS, JOHN A | reporter.nih.gov |
| Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-Extrinsic and Cell-Intrinsic Alterations at Middle Age | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,186,502 | August 1, 2018 | April 30, 2028 | TROWBRIDGE, JENNIFER JEAN | reporter.nih.gov |
| Molecular control of a novel transitional cell state in alveolar regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,185,590 | July 1, 2020 | June 30, 2029 | TATA, PURUSHOTHAMA RAO | reporter.nih.gov |
| Investigation of a neuromesendodermal progenitor population in the posterior avian endoderm | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,183,686 | August 1, 2021 | May 31, 2027 | NERURKAR, NANDAN L | reporter.nih.gov |
| Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem Cells | NIH | National Cancer Institute | 2022 to 2025 | $2,177,395 | March 1, 2022 | January 31, 2027 | GANESH, KARUNA | reporter.nih.gov |
| PI3 Kinase Inactivation in Myelodysplastic Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,173,122 | September 1, 2022 | May 31, 2027 | GRITSMAN, KIRA | reporter.nih.gov |
| Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies | NIH | National Cancer Institute | 2022 to 2025 | $2,169,942 | April 1, 2022 | March 31, 2027 | TONG, WEI | reporter.nih.gov |
| lncRNA regulation of glioblastoma progression and therapeutic resistance | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,168,484 | December 1, 2021 | November 30, 2026 | YU, JENNIFER S | reporter.nih.gov |
| ZIP8-dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and Fibrosis | NIH | National Institute on Aging | 2022 to 2025 | $2,167,288 | August 1, 2022 | April 30, 2027 | LIANG, CAROL JIURONG | reporter.nih.gov |
| Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences | NIH | National Institute on Aging | 2023 to 2025 | $2,164,800 | September 1, 2023 | May 31, 2028 | BICK, ALEXANDER | reporter.nih.gov |
| Rewiring the Injured Brain with GABA Progenitors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,163,757 | February 15, 2016 | March 31, 2027 | HUNT, ROBERT F | reporter.nih.gov |
| The Role of NMD in Cortical Neural Progenitor Cells | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,162,010 | December 1, 2021 | November 30, 2026 | ZHENG, SIKA | reporter.nih.gov |
| Tissue Size and Precision Control in Growing Hair Follicles | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,161,494 | February 1, 2022 | November 30, 2026 | PLIKUS, MAKSIM V | reporter.nih.gov |
| Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells - Diversity Supplement | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,161,211 | December 10, 2024 | May 31, 2025 | NAM, SEUNG HA | reporter.nih.gov |
| The role of P16Ink4a in adult skeletal muscle stem cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,160,052 | August 17, 2021 | May 31, 2026 | FEELEY, BRIAN | reporter.nih.gov |
| The transcription factor c-MYC in lymphocyte expansion and restriction of stemness | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,159,884 | September 25, 2017 | July 31, 2028 | EGAWA, TAKESHI | reporter.nih.gov |
| Atherothrombosis in JAK2V617F clonal hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,159,282 | June 1, 2019 | May 31, 2028 | WANG, NAN | reporter.nih.gov |
| Regulation of cellular plasticity and regeneration in Drosophila spermatogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,153,352 | June 1, 2020 | March 31, 2030 | MATUNIS, ERIKA L | reporter.nih.gov |
| Pathological Myeloid Activation After Sepsis and Trauma | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,151,320 | June 1, 2021 | March 31, 2027 | EFRON, PHILIP A | reporter.nih.gov |
| Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,149,845 | August 13, 2024 | May 31, 2029 | AULETTA, JEFFERY J | reporter.nih.gov |
| Developmentally Regulated Enhancers and Chromatin Architecture in Human Neurogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,149,369 | August 15, 2022 | May 31, 2027 | PLACANTONAKIS, DIMITRIS G. | reporter.nih.gov |
| Discriminating EGFR function in T cells and epithelium during immune-mediated tissue damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,147,877 | August 25, 2018 | June 30, 2028 | HANASH, ALAN M | reporter.nih.gov |
| Analysis of Cellular Plasticity in White Adipose Tissue. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,147,147 | May 15, 2003 | June 30, 2028 | GRANNEMAN, JAMES G | reporter.nih.gov |
| Histone Demethylases and Trophoblast Differentiationt | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,146,662 | August 1, 2021 | July 31, 2027 | PAUL, SOUMEN | reporter.nih.gov |
| Clickable Extracellular Vesicles to Silk-Based Biomaterials for Regenerative Medicine | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $2,144,591 | September 1, 2023 | July 31, 2028 | VORP, DAVID ALAN | reporter.nih.gov |
| Role of PRC1 in RUNX1-ETO-mediated transcriptional control | NIH | National Cancer Institute | 2021 to 2025 | $2,144,475 | July 5, 2021 | December 31, 2026 | HODGES, EMILY | reporter.nih.gov |
| Human/Animal Brain Chimera in drugs of abuse and HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,144,306 | August 15, 2022 | May 31, 2027 | AL-HARTHI, LENA | reporter.nih.gov |
| Vascular Regeneration with Direct Reprogramming and Engineering Strategies | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,143,183 | August 1, 2022 | July 31, 2026 | YOON, YOUNG-SUP | reporter.nih.gov |
| Defining mechanisms driving dry eye disease progression | NIH | National Eye Institute | 2021 to 2025 | $2,142,678 | August 1, 2021 | July 31, 2026 | KNOX, SARAH MONICA | reporter.nih.gov |
| Role of GM-CSF in Alveolar Macrophage Self-Renewal | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,138,005 | December 1, 2021 | November 30, 2026 | ARUMUGAM, PARITHA | reporter.nih.gov |
| The role of macrophage subpopulations in the rejuvenation of fracture repair | NIH | National Institute on Aging | 2021 to 2025 | $2,137,929 | April 1, 2021 | December 31, 2026 | ALMAN, BENJAMIN AARON | reporter.nih.gov |
| Reprogramming myogenic regulatory factors in RMS to promote differentiation and halt growth | NIH | National Cancer Institute | 2023 to 2025 | $2,136,435 | May 16, 2023 | April 30, 2028 | FORD, HEIDE L. | reporter.nih.gov |
| Cell adhesion and tissue dynamics in the skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,136,170 | December 1, 1980 | August 31, 2028 | FUCHS, ELAINE | reporter.nih.gov |
| Gene Edited and Engineered Tumor Cell Therapeutics for Cancer | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,135,976 | April 15, 2021 | March 31, 2026 | SHAH, KHALID A | reporter.nih.gov |
| Use of CTEP portfolio compounds to counteract phenotype conversion in GBM | NIH | National Cancer Institute | 2022 to 2025 | $2,134,457 | January 1, 2022 | December 31, 2026 | PAJONK, FRANK | reporter.nih.gov |
| Machine Learning to identify Biomarkers for Risk of Chronic Graft-Versus-Host Disease | NIH | National Cancer Institute | 2022 to 2025 | $2,133,819 | December 2, 2021 | November 30, 2026 | PACZESNY, SOPHIE | reporter.nih.gov |
| Role of FGF23 in Bone, Kidney, Blood, Crosstalk in Sickle Cell Disease Mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,133,643 | April 1, 2022 | January 31, 2027 | HURLEY, MARJA MARIE | reporter.nih.gov |
| The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML | NIH | National Cancer Institute | 2022 to 2025 | $2,133,556 | January 1, 2022 | December 31, 2026 | MARCUCCI, GUIDO | reporter.nih.gov |
| Targeting colorectal cancer stem cells with ALDH1B1 antagonists | NIH | National Cancer Institute | 2021 to 2025 | $2,133,438 | June 1, 2021 | May 31, 2026 | CHEN, JAMES K | reporter.nih.gov |
| The role of Kmt2c/MLL3 in hematopoietic stem cell self-renewal, commitment and exhaustion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,132,248 | April 1, 2020 | March 31, 2028 | MAGEE, JEFFREY ALAN | reporter.nih.gov |
| Genomics of AML Prognosis | NIH | National Cancer Institute | 2021 to 2025 | $2,130,312 | April 1, 2008 | June 30, 2027 | LAMBA, JATINDER K. | reporter.nih.gov |
| Endometrial epithelial stem cells and cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,130,125 | June 1, 2021 | May 31, 2027 | NIKITIN, ALEXANDER Y. | reporter.nih.gov |
| Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis | NIH | National Institute on Aging | 2022 to 2025 | $2,128,718 | July 15, 2022 | March 31, 2027 | CALVI, LAURA M | reporter.nih.gov |
| Functional interaction of transcriptional regulators in endocrine lineage specification | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,125,269 | January 1, 2023 | December 31, 2027 | STOFFERS, DORIS A | reporter.nih.gov |
| The role of satellite cells in skeletal muscle hypertrophy with aging | NIH | National Institute on Aging | 2021 to 2025 | $2,124,992 | August 15, 2021 | April 30, 2026 | MCCARTHY, JOHN JOSEPH | reporter.nih.gov |
| A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | NIH | National Cancer Institute | 2022 to 2025 | $2,123,519 | January 1, 2022 | December 31, 2026 | CALABRETTA, BRUNO | reporter.nih.gov |
| mRNA stability and its impact on hematopoiesis and acute leukemia | NIH | National Cancer Institute | 2022 to 2025 | $2,122,727 | January 1, 2022 | December 31, 2026 | AIFANTIS, IANNIS | reporter.nih.gov |
| Mapping the dynamics of mouse neurogenesis in autism models using high-resolution genomic barcoding technologies | NIH | National Human Genome Research Institute | 2022 to 2025 | $2,122,481 | September 16, 2022 | June 30, 2027 | KALHOR, REZA | reporter.nih.gov |
| Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia | NIH | National Cancer Institute | 2023 to 2025 | $2,121,560 | August 1, 2023 | July 31, 2028 | VAKOC, CHRISTOPHER | reporter.nih.gov |
| Novel longevity enhancing pathways regulated by mTOR | NIH | National Institute on Aging | 2022 to 2025 | $2,120,259 | July 1, 2022 | March 31, 2027 | SELL, CHRISTIAN | reporter.nih.gov |
| Cellular plasticity and lineage in mammalian digit tip regeneration | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,119,038 | August 3, 2022 | July 31, 2027 | LEHOCZKY, JESSICA A | reporter.nih.gov |
| Mechanisms controlling epicardial-dependent promotion of heart regeneration in zebrafish. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,118,750 | July 5, 2021 | June 30, 2027 | CAO, JINGLI | reporter.nih.gov |
| Influence of sleep on the hematopoietic niche and atherosclerosis during aging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,113,125 | July 1, 2021 | May 31, 2026 | MCALPINE, CAMERON STUART | reporter.nih.gov |
| Epigenetic dysregulation of muscle differentiation in Kabuki syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,111,652 | February 2, 2022 | December 31, 2026 | GUSSONI, EMANUELA | reporter.nih.gov |
| Investigating hematopoietic stem cell dysfunction during sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,111,564 | April 1, 2023 | March 31, 2027 | MCKINNEY-FREEMAN, SHANNON L | reporter.nih.gov |
| Mechanisms Driving Metabolic Shifts in the Intestinal Epithelium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,108,276 | September 23, 2021 | May 31, 2027 | VERZI, MICHAEL P. | reporter.nih.gov |
| MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies | NIH | National Cancer Institute | 2021 to 2025 | $2,103,010 | January 9, 2021 | December 31, 2026 | GIUS, DAVID | reporter.nih.gov |
| A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,102,265 | April 1, 2022 | March 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Airway Basal Progenitor Dysfunction in the Detection, Progression and Pathogenesis of Early COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,100,530 | August 15, 2023 | July 31, 2028 | VANDIVIER, RICHARD W | reporter.nih.gov |
| Leukemia stem cell regulation and resistance | NIH | National Cancer Institute | 2021 to 2025 | $2,100,068 | February 15, 2021 | January 31, 2026 | BHATIA, RAVI | reporter.nih.gov |
| Hox-Regulated MSCs in Skeletal Development, Growth and Fracture Healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,099,262 | July 8, 2022 | June 30, 2027 | WELLIK, DENEEN M | reporter.nih.gov |
| Skeletal Muscle Regeneration from Pluripotent Stem Cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,097,940 | June 1, 2021 | May 31, 2027 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Uncovering the functional diversification mechanisms of transcription factor isoforms involved in stem cell differentiation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,096,585 | August 1, 2021 | May 31, 2027 | SHEYNKMAN, GLORIA | reporter.nih.gov |
| Immuno and Epigenetics of Hematopoietic Cell Transplantation | NIH | National Cancer Institute | 2021 to 2025 | $2,093,460 | August 1, 2017 | April 30, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Epigenetic mechanisms of gene regulation in nephron progenitor cell proliferation and differentiation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,088,471 | July 1, 2021 | June 30, 2027 | RAUCHMAN, MICHAEL I | reporter.nih.gov |
| A developmental engineering toolbox for controlled epithelial morphogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,088,018 | August 1, 2019 | July 31, 2029 | HUGHES, ALEX | reporter.nih.gov |
| DEFINING REGULATORY ROLES FOR HISTONE H3 METHYLATION IN DEVELOPMENT | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,087,570 | July 15, 2021 | March 31, 2027 | BRUMBAUGH, JUSTIN | reporter.nih.gov |
| Neuronal responses to chronic demyelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,087,270 | April 1, 2021 | January 31, 2026 | EMERY, BEN | reporter.nih.gov |
| Structure and Functionof Nanog in Stem Cell Pluripotency | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,086,645 | January 1, 2018 | May 31, 2027 | FERREON, JOSEPHINE CHU | reporter.nih.gov |
| HIV-1 and amyloid beta interactions at the blood-brain barrier | NIH | National Institute of Mental Health | 2021 to 2025 | $2,085,676 | September 20, 2005 | July 31, 2028 | TOBOREK, MICHAL | reporter.nih.gov |
| Function and fitness consequences of human genetic variation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,084,055 | August 21, 2019 | June 30, 2029 | MCCOY, RAJIV CHAMPION | reporter.nih.gov |
| Development and vascularity of intestinal mesenchyme | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,083,022 | June 1, 2019 | April 30, 2028 | SHIVDASANI, RAMESH A | reporter.nih.gov |
| Mechanisms of cellular crosstalk in tumor-promoting niche formation | NIH | National Cancer Institute | 2021 to 2025 | $2,081,592 | December 1, 2020 | November 30, 2026 | OSHIMORI, NAOKI | reporter.nih.gov |
| Vitamin D Deficiency, Insulin Resistance and Cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,078,647 | April 15, 2010 | March 31, 2027 | BERNAL-MIZRACHI, CARLOS | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of California, San Francisco | San Francisco, CA | 59 | $94.4 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 50 | $83.8 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 12 | $80.5 million | 0 | $0 |
| Stanford University | Stanford, CA | 54 | $73.8 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 58 | $69 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 42 | $64.9 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 46 | $64 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 45 | $63 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 53 | $63 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 37 | $58.5 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 31 | $57.9 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 35 | $57.1 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 25 | $56 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 38 | $54 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 33 | $47.4 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 31 | $45.9 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 29 | $45.3 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 34 | $44.8 million | 0 | $0 |
| Duke University | Durham, NC | 42 | $44.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 34 | $43.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 38 | $42.4 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 31 | $39.4 million | 0 | $0 |
| Yale University | New Haven, CT | 30 | $39.1 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 20 | $37.6 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 26 | $37.5 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 28 | $37.3 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 7 | $36 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 22 | $35.9 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 29 | $35.6 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 34 | $33 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 22 | $31.2 million | 0 | $0 |
| University of Florida | Gainesville, FL | 21 | $31.2 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 21 | $30.9 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 27 | $29.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 13 | $29.3 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 18 | $29.3 million | 0 | $0 |
| Emory University | Atlanta, GA | 25 | $28.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 23 | $28 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 21 | $28 million | 0 | $0 |
| University of Rochester | Rochester, NY | 19 | $27.4 million | 0 | $0 |
| University of Washington | Seattle, WA | 21 | $25.5 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 21 | $25.3 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 17 | $23.7 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 19 | $22.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 21 | $22.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 20 | $22.7 million | 0 | $0 |
| University of California at Davis | Davis, CA | 20 | $22.6 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 14 | $22.5 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 16 | $21.9 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 16 | $21.8 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 13 | $20.4 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 20 | $20.3 million | 0 | $0 |
| Ohio State University | Columbus, OH | 12 | $19.9 million | 0 | $0 |
| University of Chicago | Chicago, IL | 18 | $19.9 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 13 | $19.5 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 14 | $16.3 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 13 | $15.3 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 14 | $14.9 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 9 | $14.8 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 11 | $14.6 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 10 | $14.4 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 8 | $14.3 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 10 | $13.8 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 6 | $13.4 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 8 | $13.3 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 13 | $13.2 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 10 | $13 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 8 | $12.4 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 9 | $12.3 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 8 | $12 million | 0 | $0 |
| Harvard University | Cambridge, MA | 9 | $12 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 13 | $11.5 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 5 | $11 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 9 | $10.9 million | 0 | $0 |
| Rockefeller University | New York, NY | 7 | $10.9 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 6 | $10.9 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 9 | $10.3 million | 0 | $0 |
| Roswell Park Cancer Institute Corp | Buffalo, NY | 5 | $10.1 million | 0 | $0 |
| Columbia University | New York, NY | 8 | $10.1 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 6 | $9.8 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 14 | $9.7 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 12 | $9.4 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 6 | $9.2 million | 0 | $0 |
| Cornell University | Ithaca, NY | 10 | $8.9 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 9 | $8.7 million | 0 | $0 |
| Georgia Tech Research Corporation | Atlanta, GA | 7 | $8.6 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 8 | $8.4 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 7 | $8 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 6 | $7.4 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 5 | $7.4 million | 0 | $0 |
| University of California-Santa Cruz | Santa Cruz, CA | 4 | $7.4 million | 0 | $0 |
| Rogosin Institute | New York, NY | 1 | $7.4 million | 0 | $0 |
| Joslin Diabetes Center | Boston, MA | 3 | $7.2 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 4 | $7.2 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 5 | $6.9 million | 0 | $0 |
| William Marsh Rice University | Houston, TX | 5 | $6.9 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 3 | $6.8 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 5 | $6.8 million | 0 | $0 |
| Texas Biomedical Research Institute | San Antonio, TX | 2 | $6.6 million | 0 | $0 |
| Hackensack University Medical Center | Hackensack, NJ | 3 | $6.4 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 2,265 | $1,082,096,476 | 0 | $0 |
| 2024 | 1,623 | $756,487,454 | 0 | $0 |
| 2023 | 1,146 | $583,276,269 | 0 | $0 |
| 2022 | 788 | $414,480,604 | 0 | $0 |
| 2021 | 475 | $246,987,189 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.